Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
October 11, 2023 at 03:59 AM EDT
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
